ERBB2 and neoplasm: HER2 status was reassessed in the metastatic brain specimen to confirm concordance with the primary tumor, acknowledging known intratumoral and intertumoral heterogeneity in HER2 expression in gastric carcinoma, which has significant treatment implications.